Knockdown of receptor for advanced glycation end products attenuate 17α-ethinyl-estradiol dependent proliferation and survival of MCF-7 breast cancer cells

Biochimica et Biophysica Acta - General Subjects

Volumn 1840, Issue 3, 2014, Pages 1083-1091

  Lata, Kusum ^a   Mukherjee, Tapan K ^a,b  

^a INDIAN INSTITUTE OF SCIENCE EDUCATION AND RESEARCH MOHALI   (India)

^b MAHARISHI MARKANDESHWAR DEEMED TO BE UNIVERSITY   (India)

Author keywords

17 alpha ethinyl estradiol; Estrogen receptor related receptor gamma; MCF 7 breast cancer cells proliferation and survival; Reactive oxygen species; Receptor for advanced glycation product

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; CATALASE; CELL CYCLE PROTEIN; CELL CYCLE PROTEIN CYCLIN D1; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR RELATED RECEPTOR GAMMA; ETHINYLESTRADIOL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHOLIPID HYDROPEROXIDE GLUTATHIONE PEROXIDASE; PROTEIN BCL 2; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG;

AEROBIC METABOLISM; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION;

17-ALPHA-ETHINYL ESTRADIOL; ESTROGEN RECEPTOR RELATED RECEPTOR GAMMA; MCF-7 BREAST CANCER CELLS PROLIFERATION AND SURVIVAL; REACTIVE OXYGEN SPECIES; RECEPTOR FOR ADVANCED GLYCATION PRODUCT;

CELL PROLIFERATION; CELL SURVIVAL; CYCLIN D1; ETHINYL ESTRADIOL; FEMALE; HUMANS; MCF-7 CELLS; NF-KAPPA B; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; REACTIVE OXYGEN SPECIES; RECEPTORS, ESTROGEN; RECEPTORS, IMMUNOLOGIC;

EID: 84890542239     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2013.11.014     Document Type: Article

References (54)

1. M.E. Wierman Sex steroid effects at target tissues: mechanisms of action Adv. Physiol. Educ. 31 2007 26 33
2. L.P. Shulman The state of hormonal contraception today: benefits and risks of hormonal contraceptives: combined estrogen and progestin contraceptives Am. J. Obstet. Gynecol. 205 2011 S9 S13
3. A.L. Rogerio Benefits and risks of estrogen replacement therapy Am. J. Obstet. Gynecol. 173 1995 982 989
4. K.L. Goa, G.T. Warne, and S.E. Easthope Transdermal ethinylestradiol/ norelgestromin: A review of its use in hormonal contraception Treat. Endocrinol. 2 2003 191 206 (Pubitemid 36841421)
5. J. Russo, L.M. Hasan, G. Balogh, S. Guo, and I.H. Russo Estrogen and its metabolites are carcinogenic agents in human breast epithelial cells J. Steroid Biochem. Mol. Biol. 87 2003 1 25 (Pubitemid 37421335)
6. J. Matthews, and J.A. Gustafsson Estrogen signaling: a subtle balance between ER alpha and ER beta Mol. Interv. 3 2003 281 292
7. N. Jichi, T. Shigekawa, K. Ikeda, K. Horie-Inoue, T. Fujimura, and H. Tsuda Estrogen-related receptor γ modulates cell proliferation and estrogen signaling in breast cancer J. Steroid Biochem. Mol. Biol. 123 2011 1 7
8. R.B. Riggins, J.P. Lan, Y. Zhu, U. Klimach, A. Zwart, and L.R. Cavalli ERRγ mediates Tamoxifen resistance in novel models of invasive lobular breast cancer Cancer Res. 68 2008 8908 8917
9. T.K. Mukherjee, P.R. Reynolds, and J.R. Hoidal Differential effect of estrogen receptor alpha and beta agonists on the receptor for advanced glycation end product expression in human microvascular endothelial cells Biochim. Biophys. Acta 1745 2005 300 309 (Pubitemid 41330784)
10. M. Neeper, A.M. Schmidt, J. Brett, S.D. Yan, F. Wang, and Y.C. Pan Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins J. Biol. Chem. 267 1992 14987 14997
11. S.D. Yan, A.M. Schmidt, G.M. Anderson, J. Zhang, J. Brett, and Y.S. Zou Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins J. Biol. Chem. 269 1994 9889 9897 (Pubitemid 24196599)
12. E. Leclerc, G. Fritz, S.W. Vetter, and C.W. Heizmann Binding of S100 proteins to RAGE: An update Biochim. Biophys. Acta 1793 2009 993 1007
13. M.A. Hofmann, S. Drury, C. Fu, W. Qu, A. Taguchi, Y. Lu, C. Avila, N. Kambham, A. Bierhaus, P. Nawroth, M.F. Neurath, T. Slattery, D. Beach, J. McClary, M. Nagashima, J. Morser, D. Stern, and A.M. Schmidt RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides Cell 97 1999 889 901 (Pubitemid 29375048)
14. S. Ghavami, I. Rashedi, B.M. Dattilo, M. Eshraghi, W.J. Chazin, M. Hashemi, S. Wesselborg, C. Kerkhoff, and M. Los S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway J. Leukoc. Biol. 83 2008 1484 1492 (Pubitemid 351960330)
15. S.R. Datta, A. Brunet, and M.E. Greenberg Cellular survival: a play in three Akts Genes Dev. 13 1999 2905 2927
16. P.N. Kelly, and A. Strasser The role of Bcl-2 and its pro-survival relatives in tumourigenesis and cancer therapy Cell Death Differ. 9 2011 1414 1424
17. E.S. Ginsburg, X. Gao, B.F. Shea, and R.L. Barbieri Half-life of estradiol in postmenopausal women Gynecol. Obstet. Invest. 45 1998 45 48 (Pubitemid 28033364)
18. T.K. Mukherjee, L. Nathan, H. Dinh, and S.T. Reddy Chaudhuri G17-epiestriol, an estrogen metabolite, is more potent than estradiol in inhibiting vascular cell adhesion molecule 1 (VCAM-1) mRNA expression J. Biol. Chem. 278 2003 11746 11752 (Pubitemid 36800142)
19. P.G. Gunasekar, A.G. Kanthasamy, J.L. Borowitz, and G.R. Isom Monitoring intracellular nitric oxide formation by dichlorofluorescein in neuronal cells J. Neurosci. Methods 61 1995 15 21
20. M.W. Nasser, Z. Qamri, Y.S. Deol, J. Ravi, C.A. Powell, P. Trikha, R.A. Schwendener, X.F. Bai, K. Shilo, X. Zou, G. Leone, R. Wolf, S.H. Yuspa, and R.K. Ganju S100A7 enhances mammary tumorigenesis through upregulation of inflammatory pathways Cancer Res. 72 2012 604 615
21. C. Gebhardt, A. Riehl, M. Durchdewald, J. Nemeth, G. Furstenberger, K. Muller-Decker, A. Enk, B. Arnold, A. Bierhaus, P.P. Nawroth, J. Hess, and P. Angel RAGE signaling sustains inflammation and promotes tumor development J. Exp. Med. 205 2008 275 285 (Pubitemid 351281593)
22. O. Turovskaya, D. Foell, P. Sinha, T. Vogl, R. Newlin, J. Nayak, M. Nguyen, A. Olsson, P.P. Nawroth, A. Bierhaus, N. Varki, M. Kronenberg, H.H. Freeze, and G. Srikrishna RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis Carcinogenesis 29 2008 2035 2043
23. S.F. Doisneau-Sixou, C.M. Sergio, J.S. Carroll, R. Hui, E.A. Musgrove, and R.L. Sutherland Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells Endocr. Relat. Cancer 10 2003 179 186 (Review) (Pubitemid 36758647)
24. T.K. Mukherjee, S. Mukhopadhyay, and J.R. Hoidal The role of reactive oxygen species in TNFα dependent expression of the receptor for advanced glycation end products in human umbilical vein endothelial cells Biochim. Biophys. Acta 1744 2000 213 223
25. J. Frasor, J.M. Danes, B. Komm, K.C. Chang, C.R. Lyttle, and B.S. Katzenellenbogen Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype Endocrinology 144 2003 4562 4574 (Pubitemid 37204856)
26. H. Sauer, M. Wartenberg, and J. Hescheler Reactive oxygen species as intracellular messengers during cell growth and differentiation Cell. Physiol. Biochem. 11 2001 173 186 (Pubitemid 32786086)
27. L. Altucci, R. Addeo, L. Cicatiello, S. Dauvois, M.G. Parker, M. Truss, M. Beato, V. Sica, F. Bresciani, and A. Weisz 17beta-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells Oncogene 12 1996 2315 2324 (Pubitemid 26192711)
28. J.L. Martindale, and N.J. Holbrook Cellular response to oxidative stress: signaling for suicide and survival J. Cell. Physiol. 192 2002 1 15 (Pubitemid 34587382)
29. M. Gao, L.H. Wei, P.M. Sun, J.L. Wang, D. Zhao, C. Zhao, and Z.Q. Wang Regulation of orphan receptor ERR alpha by estrogen and progesterone in endometrial carcinoma cell line Beijing Da Xue Xue Bao 37 2005 281 283
30. M. Karin, and Y. Ben-Neriah Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity Annu. Rev. Immunol. 18 2000 621 663 (Pubitemid 30365393)
31. N. Tanaka, H. Yonekura, S. Yamagishi, H. Fujimori, Y. Yamamoto, and H. Yamamoto The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-alpha through nuclear factor-kappa B, and by 17beta-estradiol through Sp-1 in human vascular endothelial cells J. Biol. Chem. 275 2000 25781 25790
32. M.J. Morgan, and Z.G. Liu Crosstalk of reactive oxygen species and NF-κB signaling Cell Res. 21 2011 103 115
33. D. Roy, Q. Cai, Q. Felty, and S. Narayan Estrogen-induced generation of reactive oxygen and nitrogen species, gene damage, and estrogen-dependent cancers J. Toxicol. Environ. Health B Crit. Rev. 10 2007 235 257 (Pubitemid 47057178)
34. J. Sastre-Serra, A. Valle, M.M. Company, I. Garau, J. Oliver, and P. Roca Estrogen down-regulates uncoupling proteins and increases oxidative stress in breast cancer Free Radic. Biol. Med. 48 5 2010 06 512
35. D.X. Zhang, and D.D. Gutterman Mitochondrial reactive oxygen species-mediated signaling in endothelial cells Am. J. Physiol. Heart Circ. Physiol. 292 2007 2023 2031
36. T.P. Szatrowski, and C.F. Nathan Production of large amounts of hydrogen peroxide by human tumor cells Cancer Res. 51 1991 794 798
37. D.K. Benjamin, C.S. Melpo, D.S. Thomas, M. Silvia, G.B. Donald, and C.S. Charalambos Immuno-targeting of catalase to the pulmonary endothelium alleviates oxidative stress and reduces acute lung transplantation injury Nat. Biotechnol. 21 2003 392 398
38. A. Seiler, M. Schneider, H. Förster, S. Roth, E.K. Wirth, C. Culmsee, N. Plesnila, E. Kremmer, O. Rådmark, W. Wurst, G.W. Bornkamm, U. Schweizer, and M. Conrad Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent- and AIF-mediated cell death Cell Metab. 8 2008 237 248
39. M. Zafarullah, W.Q. Li, J. Sylvester, and M. Ahmad Molecular mechanisms of N-acetylcysteine actions Cell. Mol. Life Sci. 60 2003 6 20 (Pubitemid 36223114)
40. Y. Lu, W. Qin, T. Shen, L. Dou, Y. Man, S. Wang, C. Xiao, and J. Li The antioxidant N-acetylcysteine promotes atherosclerotic plaque stabilization through suppression of RAGE, MMPs and NF-κB in ApoE-deficient mice J. Atheroscler. Thromb. 18 2011 998 1008
41. G.E. Stoica, T.F. Franke, A. Wellstein, F. Czubayko, H.J. List, R. Reiter, E. Morgan, M.B. Martin, and A. Stoica Estradiol rapidly activates AKT via the erbB2 signaling pathway Mol. Endocrinol. 17 2003 818 830 (Pubitemid 36539574)
42. Y. Terada, O. Nakashima, S. Inoshita, M. Kuwahara, S. Sasaki, and F. Marumo Mitogen-activated protein kinase cascade and transcription factors: the opposite role of MKK3/6-p38K and MKK1-MAPK Nephrol. Dial. Transplant. 14 Suppl. 1 1999 45 47 (Pubitemid 29041837)
43. A. Schmidt, B. Kuhla, K. Bigl, G. Münch, and T. Arendt Cell cycle related signaling in Neuro2a cells proceeds via the receptor for advanced glycation end products J. Neural Transm. 114 2007 1413 1424 (Pubitemid 350112287)
44. K. Ishihara, K. Tsutsumi, S. Kawane, M. Nakajima, and T. Kasaoka The receptor for advanced glycation end-products (RAGE) directly binds to ERK by a D-domain-like docking site FEBS Lett. 550 2003 107 113 (Pubitemid 37281366)
45. X. Wang, J.Z. Liu, J.X. Hu, H. Wu, Y.L. Li, H.L. Chen, H. Bai, and C.X. Hai ROS-activated p38 MAPK/ERK-Akt cascade plays a central role in palmitic acid-stimulated hepatocyte proliferation Free Radic. Biol. Med. 51 2011 539 551
46. 2 in PC12 cells: mechanisms via MMP, ROS, and Bcl-2 Brain Res. 1057 2005 57 64 (Pubitemid 41338087)
47. Q. Felty, and D. Roy Mitochondrial signals to nucleus regulate estrogen-induced cell growth Med. Hypotheses 64 2005 133 141 (Pubitemid 39469254)
48. M. Subramanian, and C. Saha Up regulation of Bcl2 through ERK phosphorylation is associated with human macrophage survival in an estrogen microenvironment J. Immunol. 179 2007 2330 2338
49. D. Roy, Q. Felty, S. Narayan, and P. Jayakar Signature of mitochondria of steroidal hormones-dependent normal and cancer cells: potential molecular targets for cancer therapy Front. Biosci. 12 2007 154 173 (Pubitemid 46860210)
50. G.P. Sims, D.C. Rowe, S.T. Rietdijk, R. Herbst, and A.J. Coyle HMGB1 and RAGE in inflammation and cancer Annu. Rev. Immunol. 28 2010 367 388
51. D. Tang, R. Kang, H.J. Zeh III, and M.T. Lotze High-mobility Group Box 1 [HMGB1] and cancer Biochim. Biophys. Acta 1799 2010 131
52. L. Lin, K. Zhong, Z. Sun, G. Wu, and G. Ding Receptor for advanced glycation end products (RAGE) partially mediates HMGB1-ERKs activation in clear cell renal cell carcinoma J. Cancer Res. Clin. Oncol. 138 2012 11 22
53. J. Choi, M.K. Lee, K.H. Oh, Y.S. Kim, H.Y. Choi, S.K. Baek, K.Y. Jung, J.S. Woo, S.H. Lee, and S.Y. Kwon Interaction effect between the receptor for advanced glycation end products (RAGE) and high-mobility group box-1 (HMGB-1) for the migration of a squamous cell carcinoma cell line Tumori 97 2011 196 202
54. M. Tafani, M. Di Vitro, P. Sale, L. Pellegrini, L. Schito, S. Gentileschi, R. Bracaglia, F. Marandino, and E. Garaci Upregulation of Proinflammatory genes as adaptation to hypoxia in MCF7 cells and in human mammary invasive carcinoma microenvironment Cancer Sci. 101 2010 1014 1023